PL370379A1 - N-Tlenek prukaloprydu, sposób jego wytwarzania i zastosowanie oraz zawierająca go kompozycja i sposób jej wytwarzania - Google Patents

N-Tlenek prukaloprydu, sposób jego wytwarzania i zastosowanie oraz zawierająca go kompozycja i sposób jej wytwarzania

Info

Publication number
PL370379A1
PL370379A1 PL370379A PL37037903A PL370379A1 PL 370379 A1 PL370379 A1 PL 370379A1 PL 370379 A PL370379 A PL 370379A PL 37037903 A PL37037903 A PL 37037903A PL 370379 A1 PL370379 A1 PL 370379A1
Authority
PL
Poland
Prior art keywords
prucalopride
oxide
compositions
novel
concerned
Prior art date
Application number
PL370379A
Other languages
English (en)
Other versions
PL214274B1 (pl
Inventor
Joannes Adrianus Jacobus Schuurkes
Willy Joannes Carolus Van Laerhoven
Original Assignee
Movetis N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Movetis N.V. filed Critical Movetis N.V.
Publication of PL370379A1 publication Critical patent/PL370379A1/pl
Publication of PL214274B1 publication Critical patent/PL214274B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Niniejszy wynalazek dotyczy nowej pochodnej benzamidu i jej farmaceutycznie dopuszczalnych soli addycyjnych z kwasami, kompozycji farmaceutycznych zawierających ten nowy związek, sposobów wytwarzania wymienionych związków i kompozycji oraz ich zastosowania jako leków w leczeniu zaburzeń ruchliwości układu pokarmowego.
PL370379A 2002-01-16 2003-01-13 N-Tlenek prukaloprydu, sposób jego wytwarzania i zastosowanie oraz zawierająca go kompozycja i sposób jej wytwarzania PL214274B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075157 2002-01-16
PCT/EP2003/000276 WO2003059906A1 (en) 2002-01-16 2003-01-13 Prucalopride-n-oxide

Publications (2)

Publication Number Publication Date
PL370379A1 true PL370379A1 (pl) 2005-05-16
PL214274B1 PL214274B1 (pl) 2013-07-31

Family

ID=8185531

Family Applications (1)

Application Number Title Priority Date Filing Date
PL370379A PL214274B1 (pl) 2002-01-16 2003-01-13 N-Tlenek prukaloprydu, sposób jego wytwarzania i zastosowanie oraz zawierająca go kompozycja i sposób jej wytwarzania

Country Status (18)

Country Link
US (2) US20050085510A1 (pl)
EP (1) EP1467991B1 (pl)
JP (1) JP2005514458A (pl)
KR (1) KR101023433B1 (pl)
CN (1) CN1330646C (pl)
AT (1) ATE295845T1 (pl)
AU (1) AU2003206722B2 (pl)
CA (1) CA2471729C (pl)
DE (1) DE60300683T2 (pl)
ES (1) ES2242940T3 (pl)
IL (1) IL163025A (pl)
MX (1) MXPA04006888A (pl)
NO (1) NO326580B1 (pl)
NZ (1) NZ533041A (pl)
PL (1) PL214274B1 (pl)
RU (1) RU2301806C2 (pl)
WO (1) WO2003059906A1 (pl)
ZA (1) ZA200405654B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007023141A1 (en) * 2005-08-22 2007-03-01 Solvay Pharmaceuticals B.V. N-oxides as prodrugs of piperazine & piperidine derivatives
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
AR058022A1 (es) * 2005-08-22 2008-01-23 Solvay Pharm Bv Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
WO2007109121A2 (en) * 2006-03-16 2007-09-27 Adam Rich A zebrafish model for assessing gastrointestinal motility
EP3413891B1 (en) 2016-02-11 2024-01-03 Symed Labs Limited Processes for the preparation of highly pure prucalopride succinate
CN112500398A (zh) * 2020-12-24 2021-03-16 艾希尔（深圳）药物研发有限公司 一种普鲁卡必利氧化物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716587D0 (en) * 1987-07-14 1987-08-19 Shell Int Research Preparing thiophene derivatives
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
WO1996010027A1 (en) * 1994-09-27 1996-04-04 Janssen Pharmaceutica N.V. N-substituted piperidinyl bicyclic benzoate derivatives
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
TW382017B (en) * 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
NZ330263A (en) * 1996-02-15 1999-06-29 Janssen Pharmaceutica Nv Esters of 3-hydroxy-piperidinemethanol derivatives to improve gastric emptying
TW445263B (en) * 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
JP2002530334A (ja) * 1998-11-23 2002-09-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 消化不良の処置用医薬の製造のためのプルカロプリドの使用
JO2181B1 (en) * 1999-04-29 2003-04-23 شركة جانسين فارماسوتيكا ان. في Procalopride solution is taken by mouth

Also Published As

Publication number Publication date
DE60300683T2 (de) 2006-04-27
EP1467991B1 (en) 2005-05-18
NZ533041A (en) 2006-04-28
CA2471729A1 (en) 2003-07-24
EP1467991A1 (en) 2004-10-20
US8063069B2 (en) 2011-11-22
AU2003206722B2 (en) 2008-01-24
AU2003206722A1 (en) 2003-07-30
NO20043397L (no) 2004-08-16
HK1075894A1 (zh) 2005-12-30
IL163025A (en) 2010-06-16
ZA200405654B (en) 2005-09-28
US20080125464A1 (en) 2008-05-29
RU2004124844A (ru) 2006-01-20
RU2301806C2 (ru) 2007-06-27
KR101023433B1 (ko) 2011-03-25
CA2471729C (en) 2010-03-23
CN1615308A (zh) 2005-05-11
JP2005514458A (ja) 2005-05-19
KR20040074981A (ko) 2004-08-26
WO2003059906A1 (en) 2003-07-24
DE60300683D1 (de) 2005-06-23
MXPA04006888A (es) 2004-12-06
ATE295845T1 (de) 2005-06-15
NO326580B1 (no) 2009-01-12
US20050085510A1 (en) 2005-04-21
ES2242940T3 (es) 2005-11-16
PL214274B1 (pl) 2013-07-31
CN1330646C (zh) 2007-08-08

Similar Documents

Publication Publication Date Title
CA2472954A1 (en) Aza-arylpiperazines
UA83233C2 (ru) Замещенный 2-аминотетралин для лечения депрессии
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
MY136034A (en) New medicaments for the treatment of chronic obstructive pulmonary disease
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
CA2417106A1 (en) Piperazine derivatives
TW200635582A (en) Medicaments for the treatment or prevention of fibrotic diseases
WO2002070510A3 (de) Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
WO2004037807A3 (en) Medicinal arylethanolamine compounds
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
SE0104340D0 (sv) New compounds
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MY136269A (en) Novel diphenylazetidinone, process for its preparation, medicaments comprising this compound and their use
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
SE0102440D0 (sv) New compound
MXPA05010020A (es) Derivados de oxamida.
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
TW200606164A (en) New compounds
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
GB0212410D0 (en) Organic compounds
MXPA04006888A (es) Prucaloprida-n-oxido.
TW200800984A (en) New compounds
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders